Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

NCT02558374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
Ocular Hypertension

Interventions

DRUG: AR-13324 Ophthalmic Solution 0.02%
DRUG: Timolol Maleate Ophthalmic Solution 0.5% BID
OTHER: Placebo

Sponsor

Aerie Pharmaceuticals